GODDESS version 1

  • Research type

    Research Study

  • Full title

    The GestatiOnal Diabetes future DiabEteS prevention Study (GODDESS) - feasibility study

  • IRAS ID

    177238

  • Contact name

    Angus Forbes

  • Contact email

    angus.forbes@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Duration of Study in the UK

    1 years, 5 months, 31 days

  • Research summary

    Women who develop a type of diabetes during pregnancy called gestational diabetes mellitus (GDM), are at higher risk of developing type 2 diabetes (T2DM) in the future compared to women without GDM. There are also at risk of further episodes of GDM in subsequent pregnancies. An estimated 1 in 20 pregnancies in the UK are affected by GDM, and the incidence is increasing. The children of mothers with diabetes in pregnancy are more likely to be obese or develop T2DM. T2DM is associated with long-term complications, but can be delayed or prevented in populations at high risk, through lifestyle interventions promoting healthy eating, physical activity or weight loss.

    We have developed an intervention to help prevent T2DM through healthy eating, physical activity and weight loss in women with GDM, and want to undertake a feasibility study before we conduct a full scale trial of this intervention. We will recruit 60 women who have recently received a diagnosis of GDM. We will randomly assign 30 women to receive the intervention and 30 to receive usual care. Firstly we will examine the feasibility of conducting a trial through measuring the number of participants recruited and retained in the study. We will also assess acceptability of the trial and intervention from the participants' and healthcare professionals' perspectives. Secondly, we will measure a number of other factors in both groups for indications of preliminary efficacy of the intervention. These include weight loss, diet, physical activity, blood glucose, depression and diabetes risk perception. The results of this feasibility trial will be used to inform the full scale trial, where we will test the effectiveness of the intervention.

  • REC name

    London - Surrey Borders Research Ethics Committee

  • REC reference

    18/LO/0794

  • Date of REC Opinion

    25 Jun 2018

  • REC opinion

    Further Information Favourable Opinion